Shares of Intra-Cellular Therapies are surging 35% in premarket trading Monday after Johnson & Johnson said it will acquire the biopharmaceutical company for roughly $14.6 billion.
Fastenal Company (NASDAQ:FAST) will release its fourth-quarter financial results, before the opening bell, on Friday, Jan. 17, 2025. Analysts expect the Winona, Minnesota-based company to report quarterly earnings at 48 cents per share, up from 46 cents per share in the year-ago period. Fastenal projects quarterly revenue of $1.84 billion, compared to $1.76 billion a year earlier, according to data from Benzinga Pro. On Dec. 11, Stifel analyst Brian Butler downgraded Fastenal from Buy to Hold an
Also: Dimon offers new outlook on his future, Zuckerberg slams Apple.
U.S. Steel shares are jumping in premarket trading Monday after the U.S. government extended until June from next month a deadline for Nippon Steel to abandon its planned $14.1 billion acquisition of the American steelmaker.
Nvidia (NVDA) on Monday quickly slammed newly released Biden administration rules to regulate chip sales to foreign countries.
The company hopes to make the Walmart spark as recognizable as Apple's logo and Starbucks' mermaid.
(Bloomberg) -- UK assets entered a second week of declines amid growing consternation about the government’s large fiscal deficit and key inflation data this week that may show price pressures remain elevated.Most Read from BloombergA Blueprint for Better Bike LanesWhat Robotaxis Brought San FranciscoAmbitious High-Speed Rail Plans Advance in the Baltic RegionNew York, San Francisco Ranked Worst for US Traffic in City CentersSterling was the worst-performing Group-of-10 currency on Monday, dropp
US benchmark equity indexes were tracking in the red before the opening bell Monday as traders await
Analysts say the deal, which would give Biogen full control over the drug Zurzuvae, could be a smart financial move. Yet it's also unlikely to appease broader investor concerns.